Carisma, NYU Langone to develop Vpx lentiviral vector

By The Science Advisory Board staff writers

August 25, 2020 -- Carisma Therapeutics has entered into a scientific research and licensing agreement with NYU Langone Health to attain exclusive rights to develop and commercialize a Vpx lentiviral vector globally for all indications.

The Vpx lentiviral vector is effective at transducing human monocytes, macrophages, and dendritic cells. The vector will broaden the utility of Carisma's engineered monocyte and macrophage platforms by enabling integration of transgenes for long-term, durable expression.

Carisma is partnering on the project with Nathaniel Landau, PhD, a professor in the department of microbiology at the NYU Grossman School of Medicine and inventor of the Vpx lentiviral vector.

The partnership builds on Carisma's recent U.S. Food and Drug Administration clearance of an investigational new drug (IND) application for its lead product candidate, CT-0508, an anti-human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M). The company plans to begin a phase I clinical trial for the candidate in solid tumors later this year.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here